PQARX Performance — Spectrum Preferred and Capital Securities Income Fund, Class R-4
Data updated: 2026-07-24
PQARX returned +12.36% over one year to Nov 2024. Annualised returns are +1.38% over 3 years and +2.40% over 5 years. Against its Global Short-Term Corporate Bond category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $104, against $110 for the category, and to $112 over one year, against $112. Volatility over the past three years was 8.09% a year. In the 12 months to May 2026 the fund lost a net $756.9M, and assets reached $4.80B.
PQARX Growth of $100
What $100 invested in Spectrum Preferred and Capital Securities Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Short-Term Corporate Bond category average over the same months.
| Period | PQARX | Category average |
|---|---|---|
| 1 year (Dec 2023 – Nov 2024) | $112 | $112 |
| 3 years (Dec 2021 – Nov 2024) | $104 | $110 |
| 5 years (Dec 2019 – Nov 2024) | $113 | $121 |
| Since data start (Sep 2019 – Nov 2024) | $115 | $123 |
PQARX Trailing Returns
Total returns to Nov 2024, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +12.36% |
| 3 years (annualised) | +1.38% |
| 5 years (annualised) | +2.40% |
PQARX Annual Returns
Calendar-year total returns of Spectrum Preferred and Capital Securities Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2024 (Jan–Nov) | +9.22% |
| 2023 | +6.25% |
| 2022 | −10.93% |
| 2021 | +2.70% |
| 2020 | +5.20% |
| 2019 (Sep–Dec) | +3.34% |
PQARX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +1.9% | +0.4% | +1.3% | −0.9% | +1.7% | +0.6% | +1.2% | +1.6% | +1.6% | −0.4% | 0.0% | — |
| 2023 | +4.9% | −1.3% | −5.5% | +1.2% | −0.3% | +0.9% | +2.2% | −0.4% | −0.7% | −1.6% | +4.2% | +2.9% |
| 2022 | −1.6% | −2.8% | −0.7% | −3.0% | −0.8% | −4.0% | +4.5% | −1.7% | −4.2% | +0.1% | +2.3% | +0.7% |
| 2021 | −0.2% | −0.3% | +0.3% | +1.4% | +0.3% | +0.9% | +0.5% | +0.3% | 0.0% | −0.4% | −1.1% | +0.8% |
| 2020 | +1.3% | −1.3% | −12.2% | +7.0% | +1.8% | +0.9% | +3.1% | +1.8% | −0.6% | +0.5% | +2.9% | +1.1% |
| 2019 | — | — | — | — | — | — | — | — | +0.7% | +1.2% | +0.5% | +0.8% |
PQARX Risk
Risk measures from monthly returns over Dec 2021 – Nov 2024.
- 3-year volatility (annualised): 8.09%
- 3-year Sharpe ratio: -0.39 (vs 4.5% risk-free rate)
- Best month: +4.92% (Jan 2023)
- Worst month: −5.45% (Mar 2023)
PQARX Fund Flows
Monthly money in and out of Spectrum Preferred and Capital Securities Income Fund, from SEC Form N-PORT.
- 12-month net flow: −$756.9M
- 12-month gross sales (incl. reinvestments): $1.3B
- Sales ÷ redemptions: 0.63×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $84.3M | $330.9M | −$246.6M |
| Apr 2026 | $98.1M | $105.7M | −$7.6M |
| Mar 2026 | $85.6M | $131.7M | −$46.1M |
| Feb 2026 | $97.2M | $96.6M | $534K |
| Jan 2026 | $107.3M | $119.4M | −$12.0M |
| Dec 2025 | $120.2M | $192.3M | −$72.1M |
| Nov 2025 | $101.8M | $158.9M | −$57.1M |
| Oct 2025 | $123.6M | $211.9M | −$88.3M |
| Sep 2025 | $133.5M | $179.4M | −$45.9M |
| Aug 2025 | $90.1M | $109.8M | −$19.7M |
| Jul 2025 | $114.3M | $101.6M | $12.7M |
| Jun 2025 | $115.3M | $289.9M | −$174.7M |
PQARX Assets Under Management
Net assets of Spectrum Preferred and Capital Securities Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $4.80B |
| 2026-02-28 | $5.18B |
| 2025-11-30 | $5.23B |
| 2025-08-31 | $5.41B |
| 2025-05-31 | $5.50B |
| 2025-02-28 | $5.94B |
| 2024-11-30 | $6.14B |
| 2024-08-31 | $6.23B |
| 2024-05-31 | $6.05B |
| 2024-02-29 | $6.00B |
| 2023-11-30 | $5.71B |
| 2023-08-31 | $5.75B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.